THE Medicines Control Authority of Zimbabwe (MCAZ) has approved the use of the new twice-yearly HIV prevention drug, lenacapavir. This comes as the country is one of 10 countries in Africa that have been selected to receive the new HIV drug to be provided by the US government to burdened nations in partnership with the…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions